CrossrefInfokarte
Cardiovascular toxicities associated with immune checkpoint inhibitors: An updated comprehensive disproportionality analysis of the FDA adverse event reporting system
Journal of Clinical Pharmacy and Therapeutics · 2022-10 · 47 (10) · 1576-1584
DOI: 10.1111/jcpt.13707 ↗Abstract
Kein Abstract verfügbar.
EUVIMED